Trastuzumab
ADAM10ARID1AATC code L01ATC code L01XC03ATCvet code QL01XC03Academic Center for Education, Culture and ResearchActiniumAdjuvant therapyAlpha-AmanitinAmericans for Medical ProgressAnn Marie RogersAnnual pharmaceutical drug salesAnthracyclineAntibody-dependent cellular cytotoxicityAntibody-vaccine engineered constructAryoGenAxel UllrichBRCA mutationBad PharmaBarrett's esophagusBernadette PetersBernie NolanBi-specific T-cell engagerBioconBiological response modifierBiomolecular engineeringBiopharmaceuticalBiosimilarBreast Cancer Research FoundationBreast_cancerBreast cancer classificationBreast cancer managementCancer biomarkerCancer immunotherapyCancer painCancer pharmacogenomicsCarlos ArteagaCauses of cancer painCelltrionChemoimmunotherapy
Link from a Wikipage to another Wikipage
differentFrom
primaryTopic
Trastuzumab
has abstract
El trastuzumab (comercializado ...... de ovario de (CHO) en cultivo.
@es
Il Trastuzumab (venduto dalla ...... viluppato dalla Genentech Inc.
@it
Le trastuzumab (est commercial ...... is plus importante que le 4D5.
@fr
O trastuzumabe ou trastuzumab ...... tamento contra câncer de mama.
@pt
Trastuzumab – rekombinowane hu ...... 100 tysięcy dolarów rocznie).
@pl
Trastuzumab, sold under the br ...... nited States in December 2018.
@en
Трастузумаб (англ. Trastuzumab ...... ропейському Союзі в 2000 році.
@uk
تراستوزوماب أو تراست زوماب (وا ...... لغير المسيطر علبيه في السرطان.
@ar
トラスツズマブ(英: Trastuzumab)はヒト癌遺伝子 ...... 会社で、商品名は「ハーセプチン (Herceptin) 」。
@ja
曲妥珠單抗(通用名,國際非專利藥品名稱:Trastuzuma ...... 因子受體II的單株抗體,主要用於治療某些HER-2陽性乳癌。
@zh
alternative name
Herceptin, Herzuma, Ogivri, others
@en
CAS number
180288-69-1
ChEMBL
DrugBank
FDA UNII code
P188ANX8CK
KEGG
Link from a Wikipage to an external page
Wikipage page ID
page length (characters) of wiki page
Wikipage revision ID
1,024,032,969
Link from a Wikipage to another Wikipage
ATC prefix
L01
@en
ATC suffix
XC03
@en
caption
Trastuzumab Fab region binding HER2/neu
@en
CAS number
ChEMBL
ChemSpiderID
none
@en
class
Antineoplastic agent
@en
DailyMedID
Trastuzumab
@en
date
August 2017
@en
October 2016
@en
DrugBank
DB00072
@en
elimination half-life
-1036800.0
KEGG
D03257
@en
legal AU
S4
@en
legal EU
Rx-only
@en
legal US
Rx-only
@en
licence EU
yes
@en
licence US
Trastuzumab
@en
mab type
mab
@en
metabolism
Unknown, possibly reticuloendothelial system
@en
pregnancy AU
D
@en
PubChemSubstance
46,507,516
reason
Capitalization, syntax and tone.
@en
Per month?
@en
routes of administration
Intravenous, subcutaneous
@en
source
zu/o
@en
synonyms
trastuzumab-anns, trastuzumab-dkst, trastuzumab-dttb, trastuzumab-pkrb, trastuzumab-qyyp
@en
target
tradename
Herceptin, Herzuma, Ogivri, others
@en
type
mab
@en
UNII
P188ANX8CK
@en
Verifiedfields
changed
@en
verifiedrevid
470,612,477